| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/17/2001 | CN1072963C Vaccine compsns. |
| 10/17/2001 | CN1072961C Method of treating hepatitis C in non-responders to interferon treatment |
| 10/16/2001 | USRE37410 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 10/16/2001 | US6303773 Deprotection of RNA |
| 10/16/2001 | US6303771 Pth |
| 10/16/2001 | US6303769 Lerk-5 dna |
| 10/16/2001 | US6303765 Polynucleotide which codes for protein of defined amino acids sequence; recombinant production; anticarcinogenic agents; antiarthritic agents; treatment of immune disorders such as multiple sclerosis and myasthenia gravis; diagnosis |
| 10/16/2001 | US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies |
| 10/16/2001 | US6303754 Recombinant procvf |
| 10/16/2001 | US6303750 Amino acid sequences; diagnosis and treatment of rheumatoid arthritis; antiarthritic agents |
| 10/16/2001 | US6303661 Orally administering inhibitor of dipeptidyl peptidase (dp iv) or of dipeptidyl peptidase iv-like activity |
| 10/16/2001 | US6303651 Synergistic antioxidant veterinary compositions |
| 10/16/2001 | US6303637 For therapy of autoimmune disease, prophylaxis of resistance to transplantation or transplantation rejection of organs or tissues; suppressing immune system |
| 10/16/2001 | US6303588 Applying to portions of the skin of such patient which have abnormal skin cell metabolism bioactive agent comprising adenosine-5-triphosphate, quanosine-5-triphosphate and phosphinositedes and biologically acceptable carrier |
| 10/16/2001 | US6303581 Methods and kits for removing, treating, or preventing lice with driable pedicul ostatic agents |
| 10/16/2001 | US6303580 Cyclitol Containing carbohydrates from human tissue which regulate lipogenic activity |
| 10/16/2001 | US6303579 Use of calpain inhibitors to treat ocular neural pathology |
| 10/16/2001 | US6303578 For providing analgesia, relief from gastrointestinal disorders such as diarrhea, and therapy for drug dependence |
| 10/16/2001 | US6303577 Use of a peptide compound in the treatment of systemic lupus erythematosus |
| 10/16/2001 | US6303576 Contacting cell with modulating agent that comprises internalization moiety and compound having amino acid sequencel peptide analogue or peptidomimetic of compound which retains ablity to inhibit beta-catenin mediated response |
| 10/16/2001 | US6303575 Indolicidin analogs and methods of using same |
| 10/16/2001 | US6303574 Scr SH3 binding peptides and methods of isolating and using same |
| 10/16/2001 | US6303573 Heart homing peptides and methods of using same |
| 10/16/2001 | US6303572 Control of acidic gut syndrome |
| 10/16/2001 | US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis |
| 10/16/2001 | US6303569 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 10/16/2001 | US6303568 Therapeutic antimicrobial polypeptides, their use and methods for preparation |
| 10/16/2001 | US6303567 For diagnosis and therapy of amyloidogenic diseases such as alzheimer's disease |
| 10/16/2001 | US6303379 Transfected cells for use in treatment of genetic disorder |
| 10/16/2001 | US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimer*s, parkinson*s, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis |
| 10/16/2001 | US6303372 cDNA molecule encoding human CIF130 |
| 10/16/2001 | US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering |
| 10/16/2001 | US6303361 Human glandular kallikrein-1 (hK2) |
| 10/16/2001 | US6303344 Methods and compositions for polypeptide engineering |
| 10/16/2001 | US6303338 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of mammary gland cancer, and pathologic defects |
| 10/16/2001 | US6303336 Polypeptide for the use in the prevention on viral infection; viricides |
| 10/16/2001 | US6303335 Transcription factor E2F-4 |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303331 Vertebrate apoptosis gene: compositions and methods |
| 10/16/2001 | US6303328 Anticarcinogenic agents |
| 10/16/2001 | US6303321 Methods for diagnosing sepsis |
| 10/16/2001 | US6303320 Polypeptide of protein P140 and DNAs encoding it |
| 10/16/2001 | US6303318 Detecting urogenital hyperplasia; isolate proteases in sample, detecting and classify preferential proteases in sample, compare to control, amplified enzyme concentration indicates hyperplasia |
| 10/16/2001 | US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection |
| 10/16/2001 | US6303313 Method for generating libraries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules |
| 10/16/2001 | US6303312 Modifying cell phenotype; medical research and therapy |
| 10/16/2001 | US6303297 Apparatus storing and evaluating nucleotide sequences; for diagnosis and detection of genotype defects |
| 10/16/2001 | US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection |
| 10/16/2001 | US6303289 Composition and methods for the treatment of cancer and viral infections |
| 10/16/2001 | US6303153 For therapy of viral infections and stimulating the immune system |
| 10/16/2001 | US6303151 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 10/16/2001 | US6303141 Passive sustained release transdermal drug delivery system |
| 10/16/2001 | US6303138 Endothelin-based compositions for enhancing connective tissue repair |
| 10/16/2001 | US6303128 Method for protein expression |
| 10/16/2001 | US6303127 Treatment of disease states |
| 10/16/2001 | US6303126 Treatment of fibrosis by HGF |
| 10/16/2001 | US6303124 Compounds |
| 10/16/2001 | US6303121 Method of using human receptor protein 4-1BB |
| 10/16/2001 | US6303120 Inducing antibodies in a subject to an allyl-substituted pentasaccharide by administering the compound conjugated to a protein carrier at its allyl group. |
| 10/16/2001 | US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 10/16/2001 | US6303114 IL-12 enhancement of immune responses to T-independent antigens |
| 10/16/2001 | US6303113 Preservative chlorobutanol, wherein said human protein has erythropoietin-like activity or granulocyte-colony stimulating factor-like activity |
| 10/16/2001 | US6303112 Enriched platelet wound healant |
| 10/16/2001 | CA2241464C Nisin in combination with glycerol monolaurate active against helicobacter |
| 10/16/2001 | CA2181156C Macroencapsulated secretory cells |
| 10/16/2001 | CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein |
| 10/16/2001 | CA2096350C Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 10/16/2001 | CA2087969C Protease resistant pdgf and methods of use |
| 10/16/2001 | CA2073351C Lysozyme dimers and method of preparing them |
| 10/16/2001 | CA2044626C Type a platelet-derived growth factor receptor gene |
| 10/16/2001 | CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 10/16/2001 | CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 10/14/2001 | CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 10/13/2001 | CA2344089A1 Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| 10/13/2001 | CA2343850A1 Synergistic effect of a sulfonylurea and/or non-sulfonylurea k+ atp channel blocker, and a phosphodiesterase 3 type inhibitor |
| 10/12/2001 | CA2335109A1 Cxcr4 agonist treatment of hematopoietic cells |
| 10/12/2001 | CA2305036A1 Cxcr4 agonist treatment of hematopoietc cells |
| 10/11/2001 | WO2001075440A2 Schizophrenia related genes |
| 10/11/2001 | WO2001075179A2 Preprocalcitonin as tumor rejection antigen precursor and uses thereof |
| 10/11/2001 | WO2001075170A1 A functional assay of high-density lipoprotein |
| 10/11/2001 | WO2001075168A1 Control of a gene induced by oxidized lipids in human artery wall cells |
| 10/11/2001 | WO2001075164A2 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | WO2001075140A1 HYBRID CYTOKINE OF IL-7 AND β-CHAIN OF HEPATOCYTE GROWTH FACTOR |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075126A1 Novel polypeptide--- a human ribosomal protein s18-9 and polynucleotide encoding it |
| 10/11/2001 | WO2001075124A1 Novel polypeptide -- a human regulatory transcript factor 9 and polynucleotide encoding it |
| 10/11/2001 | WO2001075122A1 Novel polypeptide---a human cytochrome comprising protein 10 and polynucleotide encoding it |
| 10/11/2001 | WO2001075120A1 A novel polypeptide, a human alkylation-dna-protein cysteine methyltransferase and the polynucleotide encoding the polypeptide |
| 10/11/2001 | WO2001075119A2 21509 and 33770, novel human dehydrogenase family members and uses thereof |
| 10/11/2001 | WO2001075117A1 A novel polypeptide- human tryosinase 12 and the polynucleotide encoding said polypeptide |
| 10/11/2001 | WO2001075114A2 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof |
| 10/11/2001 | WO2001075113A2 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof |
| 10/11/2001 | WO2001075110A2 Mucin-1 specific binding members and methods of use thereof |
| 10/11/2001 | WO2001075108A1 Human ion channel protein and polynucleotides encoding the same |
| 10/11/2001 | WO2001075107A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 10/11/2001 | WO2001075105A2 Human leucine-rich repeat family member and uses thereof |
| 10/11/2001 | WO2001075104A1 Novel protein, dna thereof and process for producing the same |
| 10/11/2001 | WO2001075103A1 A novel polypeptide, human protein 9 of short-chain scorpion toxin and the polynucleotide encoding the polypeptide |
| 10/11/2001 | WO2001075101A1 A novel polypeptide- human transcription regulator 8 and the polynucleotide encoding said polypeptide |
| 10/11/2001 | WO2001075100A1 A novel polypeptide - human dna mismatch repair protein 10 and the polynucleotide encoding said polypeptide |